Nuclear Medicine Market Size, Industry Trends Report | 2031

Report Description

The global nuclear medicine market size was valued at USD 6.5 billion in 2020 and is anticipated to expand at a CAGR of 9.4% during the forecast period, 2021-2028. The growth of the market is attributed to the increasing occurrences of cancer to which the best treatment available to all patients is nuclear medicine sciences and diagnostics.

Nuclear medicine is the medical specialty that involves the application of multiple radioactive substances in the treatment and diagnostics of various complicated diseases and disorders. From nuclear medicine, a large variety of studies have been introduced such as the endoradiology where in the study of radiation emitting within the body over radiation from external sources such as X-rays are being identified from the patient’s body.

Nuclear medicine is very similar to radiology, the only key difference being the focus of emphasis is on the function of the human body alone and not on their imaging anatomy. In other words, nuclear medicine studies the body functions with respect to any body, be it disabled or disfigured.
 

Get Free Sample Report

Nuclear medicine has mainly found applications in diagnostic medical imaging and hybrid scanning techniques. According to the World Health Organization or the WHO, there has been 9.6 million deaths owing to irregular treatment of cancer. With nuclear medical diagnostics, the WHO believes that over 80% could have been saved and reported healthy. There has also been a significant rise in the cardiovascular diseases, as per the WHO report which states that more than 17.8 million have died and will increase north to 23 million by 2030.

The COVID-19 pandemic has reduced the growth of the global nuclear medicine market initially. Researchers and scientists were not able to recognize the co-relation between the coronavirus and nuclear medicine. However, upon further research, they were able to identify that nuclear medicine along with the latest radiopharmaceuticals can help produce a permanent cure for the coronavirus. This steered to hospitals, clinics, and healthcare laboratories to focus more on the development of nuclear medicine radiopharmaceuticals for the prevention and treatment of diseases and this led to its market growth in the later stages of the COVID-19 pandemic.

Nuclear Medicine Market Trends, Drivers, Restraints, and Opportunities

• Increase in occurrences of cardiovascular diseases which can be treated by nuclear medical diagnostics is the primary reason for the projection of boosting the global nuclear medicine market growth during the forecast period, 2021-2028.
• There has been a significant increase in the research and development activities leading to technological advancement of nuclear medicine which can become a major factor boosting the market growth. The introduction of radiopharmaceuticals used in various techniques including molecular imaging, a method that involves to act a biomarkers for the specific molecular processes required for the determination of onset and progress of the disease.
• High prices for the development of nuclear medicine and high cost of services from the company’s perspective is anticipated to hinder the global nuclear medicine market growth. This becomes extremely difficult to function in developing countries such as India, South Africa and Brazil where there is limited healthcare infrastructure.
• Nuclear Medicine needs to be diagnosed on favorable environments and not all patients can be able to undergo this treatment. There could be the possibility of patients being allergic to radiotherapy methods at close range. This can hamper the nuclear medicine market growth.
• R&D activities along with studies have shown that radiotherapy under the influence of nuclear medicine can be used for the treatment for complicated diseases including thyroid-related diseases, bone diseases, neurological diseases, and respiratory diseases. In July 2019, French investigators published their findings upon the demonstration of the hafnium oxide nanoparticle or the NBTXR3 to act as an enhancer for radio waves used for improving the response for soft-tissue sarcoma by using radiotherapy.

Scope of Nuclear Medicine Market Report

The report on the global nuclear medicine market size includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Nuclear Medicine Market Segment Insights

Product Segment Analysis

Based on products, the global nuclear medicine market is bifurcated into diagnostic products and therapeutic products. The diagnostic products are further bifurcated into SPECT and PET. The SPECT is again divided into TC-99m, TL-201, GA-67, I-123, and other SPECT Products. The PET products are divided into F-18, SR-82/RB-82, and other PET products. The therapeutic products are divided into Alpha emitters, Beta emitters, and Brachytherapy.

The Alpha emitters are further bifurcated into RA-223 and other Alpha emitters. The Beta emitters are divided into I-131, Y-90, SM-153, Re-186, Lu-117, and other Beta emitters. The Brachytherapy is divided into Cesium-131, Iodine-125, Palladium-103, Iridium-192, and other Brachytherapy products. The therapeutic segment is expected to constitute the major share of the market in 2019. Beta emitters in the therapeutic segment has the methodology involving the least damage to surrounding cells, travels long distances, and operate on low energy levels.

Meanwhile the diagnostic segment is anticipated to grow with a significant CAGR during the forecast period, 2021-2028. The major reason attributing to this market growth is the cost-effectivity, early diagnosis, high sensitivity, non-evasiveness, and easy to handle towards abnormalities in any structure or organ structure.

Application Segment Analysis
 

On the basis of applications, the global nuclear medicine market is divided into cardiology, oncology, thyroid, lymphoma, bone metastasis, endocrine tumor, and others. The cardiology segment is expected to constitute the major share of the market in 2019. The major reason attributing to this market growth is the low cost of procedures along with the high adoption rates.

Meanwhile the thyroid segment is anticipated to grow with a significant CAGR during the forecast period, 2021-2028. The latest techniques and technological advancements have been focused primarily upon the thyroid segment.

Get Free Sample Report

Regional Analysis

On the basis of regions, the global Nuclear Medicine market is categorized as Asia Pacific, North America, Latin America, Europe and Middle East & Africa. The market in North America is expected to constitute the largest share in 2019. This regional market growth can be attributed to the growing research & development expenditure along with the rising in adoption of the latest technology.

The demand of nuclear medicine is increasing rapidly in this region due to the presence of the major market players in the market, an advantage other regions do not have. The cost of expenditure is significantly lower in North America than that of other economies. However, the market in Asia Pacific is anticipated to expand at a significant CAGR during the forecast period, 2021-2028, as they have prioritized the cost-efficiency perspective of nuclear medicine combined with their growing population.

Get Free Sample Report